0001209191-17-055949.txt : 20171004 0001209191-17-055949.hdr.sgml : 20171004 20171004180040 ACCESSION NUMBER: 0001209191-17-055949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171002 FILED AS OF DATE: 20171004 DATE AS OF CHANGE: 20171004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: St Peter Steven CENTRAL INDEX KEY: 0001352447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35952 FILM NUMBER: 171122790 MAIL ADDRESS: STREET 1: MPM CAPITAL STREET 2: 200 CLARENDON STREET 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 BUSINESS PHONE: 913.353.1000 MAIL ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-02 0 0001509190 ARATANA THERAPEUTICS, INC. PETX 0001352447 St Peter Steven C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 1 1 0 0 PRESIDENT AND CEO Common Stock 2017-10-02 4 S 0 50000 6.2423 D 579359 D Common Stock 86997 I By LLC The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on November 8, 2016. This sale constitutes the final sale under such trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.005 to $6.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein. /s/ John C. Ayres as Attorney-in-Fact for Steven St. Peter 2017-10-04